Magic Weight Loss? Here’s the Catch…
Magic Weight Loss? Here’s the Catch…
By: Graham R. Stetson, OD, MS
Chances are you’ve heard the names Ozempic, Wegovy, and Mounjaro in the news or from a friend. Originally developed to help people with type 2 diabetes manage blood sugar, these GLP-1 receptor agonists (RAs) are making headlines for their “nearly magic” weight-loss results.
By activating areas of the brain that reduce hunger and increase feelings of fullness, GLP-1 RAs can help lower food intake and promote weight loss. The catch? Without lasting changes to eating habits, their benefits end once the medication stops. And, while most of the focus has been on shrinking waistlines, it’s important not to overlook the risks to your eye health.
For people with diabetes, GLP-1 RAs can be life-changing. By improving blood sugar control, they reduce the long-term risk of serious eye problems such as diabetic retinopathy (damage to the retina), glaucoma, and cataracts. However, if blood sugar levels drop too quickly, existing eye disease can temporarily worsen. While not unique to GLP-1 RAs (it can happen with other therapies too), it means anyone with diabetes starting these medications should be closely monitored with regular eye exams.
For those looking to lose weight, GLP-1 RAs carry some different risks. Blurred vision and dry eyes are relatively common, often tied to diet or blood sugar changes. More rarely, studies suggest a possible increased risk of non-arteritic ischemic optic neuropathy (NAION), where reduced blood flow damages the optic nerve. Though uncommon, NAION occurs about twice as often in weight-loss patients on GLP-1 RAs than in those with diabetes. Because NAION can cause sudden vision loss or distortion, it requires urgent medical attention.
If you’re taking (or considering) one of these medications, here are four steps to protect your vision:
Tell your eye doctor: Let them know you’ve started a GLP-1 RA so they can monitor your eye health more closely.
Get a baseline exam: A thorough eye exam before starting treatment provides a reference point for future changes.
Follow up regularly: Many eye conditions begin without noticeable symptoms. Stick to your doctor’s visit schedule to catch any changes early.
Report sudden symptoms: Vision loss, blurry or distorted vision, flashes, floaters, and eye pain should never be ignored.
GLP-1 RAs are powerful tools that can improve both health and quality of life, but they are not without risks. Protect your vision by staying connected with your doctors and prioritizing eye care, so you can enjoy the benefits of these medications safely.
